Materias dentro de su búsqueda.
Mostrando 421 - 440 Resultados de 579 Para Buscar '"Oña"', tiempo de consulta: 0.24s Limitar resultados
  1. 421
    “…Either 0.8 mg/mL of the optic nerve antigen homogenate (ONA; ONA 0.8) or 1.0 mg/mL ONA (ONA 1.0) were injected in 129/Sv mice. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Transfer of the Experimental Autoimmune Glaucoma Model from Rats to Mice—New Options to Study Glaucoma Disease
  2. 422
    “…In addition, we also found that ONA directly suppressed cancer cell proliferation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophages
  3. 423
    “…PURPOSE: Optic nerve avulsion (ONA) is a rare but serious presentation of ocular trauma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Optic Nerve Avulsion: Pattern and Etiologies at a Tertiary Eye Care Center in Saudi Arabia: An 8-Year Retrospective Study
  4. 424
    “…ONA are devices that have their resonating frequency in the visible range. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Gas Sensing with Bare and Graphene-covered Optical Nano-Antenna Structures
  5. 425
    “…METHODS: Six-week-old wildtype (WT+ONA) and βB1-Connective Tissue Growth Factor (CTGF) mice (CTGF+ONA) were immunized with 1 mg ONA (optic nerve antigen). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
  6. 426
    “…In addition, through the SPS reimbursement audits and benefit verification for Ona A billing, the Ona A reimbursement is projected to increase by $325,000 over 3 years due to switching Medicaid Ona A patients to bill through pharmacy benefits. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Integrating high touch specialty pharmacy services within a neurology clinic to improve medication access and affordability
  7. 427
    “…Also, 9-ONA induced platelet aggregation dose-dependently. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A lipid peroxidation product 9-oxononanoic acid induces phospholipase A(2) activity and thromboxane A(2) production in human blood
  8. 428
    “…RESULTS: Sixty-eight patients were identified receiving OnaA >400 U/session. Dystonia (n = 44) and spasticity (n = 24) were the most common indications for high-dose OnaA. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    High-dose Botulinum Toxin Therapy: Safety, Benefit, and Endurance of Efficacy
  9. 429
    “…INTRODUCTION: OnabotulinumtoxinA (ONA; Botox, Allergan, Irvine, CA) was discovered for cosmetic use in the mid-1980s for which it was FDA approved in April 2002. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Triple-Blind, Prospective, Internally Controlled Comparative Study Between AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Facial Rhytids
  10. 430
    “…An ONA:ABO ratio of 1:3 provided similar or higher efficacy, but an increased rate of adverse effects, and an ONA:ABO ratio of 1:4 was associated with higher efficacy, but with an excessive rate of intolerable side effects. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    OnabotulinumtoxinA and AbobotulinumtoxinA Dose Conversion: A Systematic Literature Review
  11. 431
    “…However, the degradation rate of g-C(3)N(4)–MeONa, g-C(3)N(4)–EtONa, and g-C(3)N(4)–(t)BuONa is 55.1%, 68.6%, and 79.1%, respectively, under the same conditions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Sodium alkoxide-mediated g-C(3)N(4) immobilized on a composite nanofibrous membrane for preferable photocatalytic activity
  12. 432
    “…Systemic anomalies have been reported with bilateral ONA, whereas unilateral ONA is seen in otherwise healthy individuals. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Optic nerve aplasia: A case series
  13. 433
    “…PhONA provides a graphical framework to select a testable and manageable number of OTUs to support microbiome-enhanced agriculture. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Integration of Phenotypes in Microbiome Networks for Designing Synthetic Communities: a Study of Mycobiomes in the Grafted Tomato System
  14. 434
    por Javed, Saqib, Fisse, Jonas, Vogt, Dieter
    Publicado 2023
    “…The catalytic depolymerization efficiency of MeONa was compared under similar conditions with widely studied zinc acetate and cobalt acetate. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Optimization and Kinetic Evaluation for Glycolytic Depolymerization of Post-Consumer PET Waste with Sodium Methoxide
  15. 435
    “…Nine of these probes were significantly upregulated in ONA animals (p < 0.05), including Hba-a1 and Cxcl10, while fifteen probes were significantly downregulated in ONA animals (p < 0.05), such as Gdf15 and Wwox. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Heat Shock Protein Upregulation Supplemental to Complex mRNA Alterations in Autoimmune Glaucoma
  16. 436
    “…RESULTS: Significantly higher levels of IgG against complexing protein were detected in onaA-tolerant sera but not in onaA-responders, leading to proposals that anti-complexing protein antibodies could cause onaA unresponsiveness. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Association Between Secondary Botulinum Toxin A Treatment Failure in Cosmetic Indication and Anti-Complexing Protein Antibody Production
  17. 437
    “…The long-term stimuli of neurons in the trigeminocervical junction may explain this situation. OnabotulinumtoxinA (ONA) treatment is one of the proven treatments for CM; however, there is no study data on the efficacy of ONA treatment on neck disability and pain in CM patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity
  18. 438
    “…There is still limited ability to predict a clinically meaningful response to OnaB-A for individual patients, however. This review summarises briefly the proposed mechanism of OnaB-A in chronic migraine, the literature of predictors of clinical response, and recent developments in the field.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    OnabotulinumtoxinA in Migraine: A Review of the Literature and Factors Associated with Efficacy
  19. 439
    “…PURPOSE: To report three cases of optic nerve aplasia (ONA). CASE REPORT: Herein three subjects with ONA are described, two subjects had unilateral involvement. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Optic Nerve Aplasia: Case Report and Literature Review
  20. 440
    “…Moreover, JNK3 was found to be upregulated after ONA and to contribute to Tuj1(+) RGC death. APP knockout reduced the ONA-induced enhanced expression of JNK3 and phosphorylated JNK (pJNK). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    APP upregulation contributes to retinal ganglion cell degeneration via JNK3
Herramientas de búsqueda: RSS